Czechia · Medical and donor conditions

An unbranded clinical microscope, sample tubes and a blank consent-review clipboard in a modern medical laboratory.
Editorial illustration only; it is not evidence of a real clinic, licence or legal approval.

Czech Republic: Medical and Donor Requirements in Surrogacy

The short answer

Czech law does not provide a separate, complete medical-eligibility checklist for surrogacy. The starting points are Act No. 373/2011 Coll. on Specific Health Services, especially §§ 3–10, and Decree No. 422/2008 Coll., Annex 5, on reproductive-cell donors. These instruments clearly regulate ordinary assisted reproduction, clinical consent and gamete safety. They do not expressly allocate every rule between intended parents and a gestational surrogate. Treat the article as a decision guide, not confirmation that a particular programme is lawful or that a clinic has accepted a case.

Which rules apply, and what remains unsettled?

Official Czech guidance says surrogacy is not expressly regulated as a separate institution, although it is not prohibited. This does not remove applicable medical rules. Embryo creation or transfer may engage general ART and tissue/cell-safety rules. Application depends on gamete source, embryo recipient, storage or processing, and the documented medical indication. The lack of a surrogacy-specific framework must be acknowledged rather than filled with clinic assumptions.

Medical indication, authorized provider and embryo testing

Section 3(1) describes assisted reproduction as a medical intervention for treating a woman’s or man’s infertility where natural conception or carrying a viable fetus is unlikely or impossible and other treatment has failed or is unlikely to succeed. It also covers early genetic testing of an embryo where the future child’s health is endangered by a demonstrable risk of transmitting a genetically conditioned disease or defect carried by the woman or man. Under § 4, treatment must be provided by a provider authorized in reproductive medicine, or, for the specified procedure of introducing sperm, by a provider authorized in gynaecology and obstetrics. Section 5(2) prohibits embryo sex selection except where it can prevent a serious sex-linked genetic disease. These are statutory rules; they are not a full surrogacy-specific clinical protocol.

Age, written request and the gestational-carrier question

Section 6 says artificial fertilization may be performed on a woman of childbearing age who has not exceeded 49 years. It requires a written request from a woman and a man intending to undergo the service together; that request must be no older than six months and is kept in the woman’s medical record. Treatment is barred where the woman is related to the man in a way that legally prevents marriage. The statute defines embryo transfer as artificial fertilization, but it does not separately explain how the age rule and joint-request wording map onto every role in a surrogacy arrangement. Do not assume that the 49-year limit automatically belongs to the intended mother, or that it can never apply to the surrogate. Ask the clinic for its written legal analysis of the specific roles.

Health assessment of the woman receiving treatment

Section 7 requires health suitability to be assessed for the people whose gametes are collected and for the woman who receives artificial fertilization. It also excludes a recipient whose legal capacity is restricted so that she cannot assess the health service or its consequences, or who is subject to specified forms of detention or custody. These are statutory requirements, not optional clinic preferences. However, the Act does not give a complete surrogate-specific list of diagnoses, BMI limits, maximum previous births, caesarean thresholds or psychological criteria. Ask which person the clinic records as the recipient, which statutory provisions it applies, and what clinical criteria it adds for the gestational carrier. The capacity restriction also covers inability to assess parental responsibility, even in part; statutory custody exclusions include a police cell, remand, prison and security detention.

Anonymous gamete donor: age and status restrictions

For an anonymous gamete donor, § 3(4) sets an age range of 18 through 35 for a woman donating eggs and 18 through 40 for a man donating sperm. Section 7(3) also contains status-based exclusions, including certain restrictions on legal capacity, detention, quarantine or isolation, and hospitalisation without consent. These age limits apply to the statutory category of an anonymous donor; they do not, by themselves, set a separate age limit for a gestational carrier. However, do not assume that an intended parent’s own gametes are automatically outside the donor rules. Section 3(4) distinguishes gametes of the woman and the man undergoing treatment with her from gametes donated by another person, and the reviewed statute does not clearly explain how that distinction applies in every surrogacy arrangement. Before relying on a partner-gamete exception or treating an intended parent as an anonymous donor, obtain a written Czech-law analysis of the proposed roles and treatment steps. First establish whose egg or sperm is being used and how the donation is legally classified. If a clinic says that a donor-age rule applies to the gestational carrier, request the exact provision and its reasoning. The donor exclusions also name a detention facility for foreigners and an asylum facility.

Information and informed consent

Before treatment, § 8 requires the provider to explain the nature of the proposed methods, their lasting consequences and possible risks, how surplus embryos may be handled, and the expected storage costs and period. The information must also address how parentage is determined under the Civil Code where a child is conceived through assisted reproduction. The couple’s written consent must be given again before each artificial fertilization, and consent to individual procedures must be recorded before they begin. In a surrogacy case, request the actual consent forms and a written explanation of whose consent is required for embryo creation, transfer, storage, further use or disposal. A signature should not be treated as proof that every role-specific legal issue has been resolved.

Partner gametes: direct use versus storage or processing

Decree No. 422/2008 Coll., Annex 5, distinguishes categories of donation. If reproductive cells are donated between partners and used directly, the decree says the donor-selection criteria and laboratory tests specified for the other categories do not have to be applied. This is a narrow exception for direct-use partner donation, not a general exemption from clinical assessment, informed consent or the safety duties that apply to the treatment. Where partner gametes are processed or stored, or used for embryo cryopreservation, the rules change: the responsible doctor must document the justification based on medical history and treatment indications, and tests must address cross-contamination risk. Positive or unavailable results for HIV, HBV, HCV or syphilis require segregated storage under the decree. Ask the clinic to identify the category in writing. A narrow exception also applies to semen processed for intrauterine insemination and not stored, if the tissue establishment proves through validated procedures that cross-contamination and staff-exposure risks are excluded.

Required screening for other donors

For donation other than between partners, Annex 5 requires a documented assessment based on age, health, medical history and behavioural history, a questionnaire, and a personal interview conducted by appropriately qualified and trained staff. The required infectious-disease screen must be negative. The table summarises the core panel; additional testing may be required depending on risk. Selection must consider risks to the future child or recipient (transmissible infection, genetic disease, harmful behaviour or reproductive-health exposures, and inherited psychotic disorders) and risks to the donor from ovarian stimulation, sedation, egg retrieval and psychological effects.

CheckRule in the reviewed decree
HIV-1/2Testing for HIV-1 and HIV-2, including the specified antibody/antigen approach; a negative result is required.
Hepatitis B (HBV)Testing includes HBsAg and anti-HBc; if anti-HBc is positive while HBsAg is negative, further investigation and risk assessment are required before suitability is determined.
Hepatitis C (HCV)Anti-HCV testing; a negative result is required.
SyphilisTesting under the specified laboratory algorithm; the required screening result must be negative for non-partner donation.
Sperm donor: Chlamydia trachomatisA urine sample is tested by nucleic-acid amplification (NAAT); a negative result is required.

The clinic should be able to confirm which samples were taken, which methods were used, when the results were obtained and whether the required release conditions were met. A marketing statement such as “fully screened” is not a substitute for a documented screening protocol.

Additional infection and genetic-risk checks

Annex 5 requires HTLV-I testing when the donor lives in or comes from a high-prevalence area, has a sexual partner from such an area, or has parents from such an area. Other tests may be selected according to donor history, recipient history, exposure, the characteristics of the cells and the epidemiological situation; examples in the decree include RhD, malaria, cytomegalovirus and Trypanosoma cruzi. The decree does not say that every conceivable infectious test is mandatory for every donor. It also requires genetic screening for autosomal-recessive genes known, on international scientific evidence, to occur in the donor’s ethnic background, and assessment of known inherited risks in the family. The recipient must receive a clear explanation of relevant risks and measures taken to reduce them. Ask for the rationale for additional tests and the explanation of residual risk, not just a list of test names.

Sample timing and sperm quarantine

For non-partner donations, blood samples are taken at each donation; for egg donation, the sample must be taken no later than the start of ovarian stimulation. Sperm donated outside the partner category must be quarantined for at least 180 days, after which repeat blood sampling and testing are required. If the sample taken at the time of donation was also tested by nucleic-acid amplification for HIV, HBV and HCV, repeat testing for those specified viruses may be omitted. That exception does not erase the stated 180-day quarantine. For partner donation that is not direct-use, the blood sample is taken within the three months before the first donation; subsequent samples from the same donor are required no later than 24 months after the previous sample. Ask for sample dates, methods, quarantine records and the legal basis for any claimed exception.

Anonymity and access to health information

Where the statutory anonymous-donor framework applies, Czech law requires anonymity between an anonymous donor, the infertile couple and the child born through assisted reproduction. Because the statute does not clearly allocate every participant’s role in surrogacy, ask the clinic to explain in writing how it classifies the participants and applies the anonymity rule to the proposed arrangement. The provider performing the artificial-fertilization procedure must retain the anonymous donor’s relevant health information for 30 years from that procedure; the statutory term includes embryo transfer. On written request, it must provide information about the donor’s health to the infertile couple or to an adult person born through assisted reproduction. This is access to health information, not a general right to learn the donor’s identity. Before signing, obtain the clinic’s written policy explaining what donor information is retained, who may request it, how requests are made and how records are protected.

Law versus clinic policy

A clinic may have stricter clinical criteria than the minimum expressly stated in legislation. For example, it may set requirements concerning the gestational carrier’s age, BMI, pregnancy and birth history, uterine health, smoking, psychological assessment or other medical risks. Do not label such a threshold “Czech law” unless the clinic identifies the actual legal provision. Equally, the absence of a number in the statute does not mean a clinician must accept a medically risky case. The useful distinction is: binding statutory requirement; other binding regulatory requirement; clinical judgment or clinic protocol; and a recommendation. Ask the clinic to identify which category each disputed condition belongs to and to provide the written policy and medical rationale.

What to obtain before treatment

Before committing to treatment, request a concise document pack: (1) the provider’s current authorization and scope for reproductive medicine; (2) a written explanation of how §§ 3, 6 and 7 apply to the intended parents and the gestational carrier; (3) the clinic’s eligibility criteria for the carrier and the medical records or assessments it requires; (4) the donor category, age eligibility, infectious screening panel, sample dates and any genetic-risk assessment; (5) the reason for additional tests and the explanation of residual risk; (6) the informed-consent forms, including embryo storage, further use and disposal; (7) the policy on donor anonymity and access to health information; and (8) a written timetable showing any six-month request validity, sample deadlines and quarantine/release requirements. Keep copies of the version of each protocol in force when the clinic accepts the case. If the clinic refuses a candidate or requests an extra test, ask for the decision in writing and separate the stated reasons into law, regulatory requirements, clinical judgment and internal policy. Request the exact provision if the clinic says the law requires a particular age, BMI, number of previous births or genetic test. If the reason is clinical, ask for the safety rationale and whether review by another clinician is available. Do not pressure a clinician to proceed against a safety assessment. A second opinion from a Czech reproductive-medicine specialist and a Czech lawyer familiar with assisted reproduction can help clarify the issue, but neither should be asked to manufacture certainty where the law is genuinely unclear.

Examples and the safest next step

Two examples show why legal classification matters. If a clinic says sperm from a non-partner donor must remain in quarantine for at least 180 days before release, Annex 5 to Decree No. 422/2008 requires that quarantine; ask for the quarantine record and evidence of the required follow-up testing. If the clinic says the intended father’s own sperm is automatically “partner donation” and therefore exempt from donor-selection criteria and laboratory tests, ask which woman and man it treats as the pair undergoing treatment together under § 3(4) of Act No. 373/2011, and why the direct-use exception in Annex 5 applies to the actual processing and storage steps. The statute does not clearly resolve every surrogacy role, so obtain the clinic’s written classification and independent Czech-law advice rather than assuming genetic relationship alone determines the category. Medical acceptance does not establish parentage or make a surrogacy agreement enforceable: official Czech guidance says maternity is based on childbirth and that the obligation to transfer the child under a surrogacy agreement is not legally enforceable. The same guidance warns that remuneration connected with pregnancy, birth and transfer may constitute a criminal offence. Obtain separate Czech legal advice before agreeing to the arrangement or any payment.

Sources and legal materials

Access date: 2026-10-22.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards